Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Ivar Vatne appointed CEO of Billerud

The Board of Billerud has appointed Ivar Vatne to be the President and CEO of Billerud. Ivar Vatne has been acting President and CEO since July 2023 and enters the permanent position with immediate effect.“The Board has conducted a thorough recruitment process and has evaluated both internal and external candidates. We are very pleased that Ivar is willing to take on the job and it shows real strength that we find the best candidate within the company. Ivar is a highly appreciated leader, and he has deep knowledge about the company’s strategic direction. He has also proved that he

#23-107 Trading halt in BellPal Holding AB

NGM has decided to halt the trading in the shares of BellPal Holding AB effective immediately. Trading will be halted until further notice in accordance with Chapter 11, Section 12 of the Securities Market Act. The trade halt is due to non-disclosure of inside information about the issuer or the issuer’s financial instruments pursuant Chapter 22, Section 1, Paragraph 3 of the Securities Market Act. The Financial Supervisory Authority has been notified about the trade halt and has decided that it will remain until further notice in accordance with Chapter 22, Section 1 of the Securities

ExpreS2ion announces new EU-funded Horizon Europe grant award for Nipah virus vaccine development

Hørsholm, Denmark, 1 December 2023 – ExpreS[2]ion Biotech Holding AB’s affiliate ExpreS[2]ion Biotechnologies ApS (“ExpreS2ion") today announces the award of a Horizon Europe grant amounting to 8 million EUR, approximately 90 million SEK, to the VICI-Disease consortium, of which 53% is direct contribution for ExpreS2ion’s part of the project costs. The aim is to obtain clinical proof-of-concept of a Nipah virus (NiV) vaccine candidate within four years.CEO Bent Frandsen comments: “This is an important project in an area of public health concern that will benefit from our advantageous

Rejlers signs framework agreement with the Swedish Transport Administration on skills supply in infrastructure

Rejlers has signed a significant framework agreement with the Swedish Transport Administration regarding the agency's strategic skills supply work. The agreement covers assistant positions, urban planners, traffic engineers, planners and investigators and extends over a period of two years with the possibility of extension for a further two years.Through the framework agreement, Rejlers will play a key role in recruiting and providing newly graduated engineers and planners to strengthen the Swedish Transport Administration's organisation. This includes entry-level positions such as urban

Invitation to presentation of Sectra’s six-month interim report 2023/2024

Linköping, Sweden – December 1, 2023 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) invites investors, analysts, and the media to a presentation of the company’s six-month report with President Torbjörn Kronander and CFO Jessica Holmquist.Publication of the financial report: 8:15 a.m. (CET) on December 15, 2023Report presentation: 10:00 a.m. (CET) on the same date To participate, follow the instructions on Sectra’s website investor.sectra.com/q2report2324 .

Change in Aiforia Technologies Plc’s Management Team

Aiforia Technologies Plc, Company Release, December 1, 2023 09:00 a.m. EET. Aiforia Technologies Plc reinforces its Management Team to strengthen the implementation of the company’s growth strategy.Panu Kauppila has been appointed Chief Product Officer and a member of the Management Team (previously Vice President of Product Management) as of 1.12.2023. He has been with the company since June 2022. Panu has played a key role in defining Aiforia's product portfolio and prioritizing product development. In particular, he has led the definition, development, and delivery of clinical product

Discontinuation of two CRYSTALIZE evidence trials

1 December 2023 Update on CRYSTALIZE evidence trials Discontinuation of STABILIZE-CKD and DIALIZE-Outcomes Phase III trials AstraZeneca has decided to discontinue the STABILIZE-CKD and DIALIZE-Outcomes Phase III evidence trials for Lokelma (sodium zirconium cyclosilicate). The decision was made due to substantially increased enrolment timelines and low event rates, respectively, which made it prohibitive to deliver study results within a timeframe to meaningfully advance clinical practice. STABILIZE-CKD and DIALIZE-Outcomes trials are part of the CRYSTALIZE evidence programme,

Arctic Bioscience – More than 75% recruited in the phase IIb HeROPA clinical trial

With reference to the Q3 update from November 2[nd] 2023 which reported more than 50% recruited patients to the phase IIb clinical trial HeROPA, Arctic Bioscience is pleased to report that we have now recruited more than 75% of the patients required for the trial.The HeROPA phase IIb clinical trial of HRO350 - a novel, oral drug candidate for the treatment of mild-to-moderate psoriasis - is ongoing in 5 countries in Europe; UK, Germany, Poland, Finland and Norway. As planned, recruitment speed has increased throughout fall as new clinics have been activated. Recruitment is going

Handelsbanken named Sweden’s “Bank of the Year 2023”

Financial affairs publication The Banker has named Handelsbanken Sweden’s “Bank of the Year 2023”. The journal, which is owned by the Financial Times and which covers the global banking sector, said Handelsbanken won the award due to its ambitious sustainability work and stable profitability. “We build long-term relationships and grow alongside our customers. This has been a successful business model for over 150 years,” says Carina Åkerström, President and CEO of Handelsbanken.The Banker, an international financial affairs publication that is part of the Financial Times Group, has named

Kährs Strengthening its US team in Growth Strategy Execution

Kährs has a solid and proven business platform with significant potential to further deliver profitable growth. Kährs business model is based on two strong business segments: Residential and Commercial. Residential is the core segment and Commercial is building momentum for growth in selected sub-segments.Kährs in the US has been successful in carving out a niche in the mid/premium market, leveraging its reputation for sustainability, innovation, quality, and design. Sean Brennan, President of Kährs International – US has been the leader of the recent growth, strategic partnerships, and

24SevenOffice Group AB announces a strategic partnership with Debet AS to increase accounting automation, customer value and scalability for smaller businesses

24SevenOffice announces a strategic partnership with Debet AS. This partnership represents an important milestone for both 24SevenOffice and Debet AS. Debet is able to offer expanded service offerings and accounting automation for their smaller customers satisfying updated regulation in the market, whilst 24SevenOffice will be the preferred system for their more than 15,000 businesses. Historically, 24SevenOffice has been recognized for delivering ERP and accounting software to medium-sized and larger, more complex customers. 24SevenOffice has for a period now strategically been building

Neste and Eppendorf forge strategic partnership to develop new line of renewable lab plastics

Neste Corporation, Press Release, 1 December 2023 at 9 a.m. (EET) Photo: Life science applications come with high quality requirements for the materials used. Source: Neste · New Eppendorf consumables range cuts the use of fossil oil as a raw material in lab plastics, offering labs a more sustainable alternative  · Neste supplies renewable Neste RE™ to replace conventional fossil feedstock in the lab plastics manufacturing Neste has joined forces with Eppendorf, a leading manufacturer and supplier of laboratory equipment, to advance the development of lab products made

NIDA funds studies on PN6047 from PharmNovo for potential opioid withdrawal treatment

The US National Institute of Drug Abuse (NIDA) has funded a project investigating the drug candidate PN6047 from PharmNovo as a potential treatment for opioid withdrawal syndrome. PN6047, a novel and highly selective Delta Opioid Receptor Agonist (DORA), represents a unique approach to addressing this medical challenge.The persistent challenge of opioid addiction, involving substances such as heroin, fentanyl, and oxycodone, remains a significant public health concern both in the United States and globally. A key obstacle in addressing this addiction crisis is the management of withdrawal

HANZA acquires Orbit One

HANZA AB (publ) has today signed an agreement to acquire all shares in Orbit One AB, a Swedish company that offers contract manufacturing of electronics and electromechanics. Orbit One has annual sales of approximately SEK 1.1 billion with an operating profit (EBITA) of approximately SEK 70 million.Orbit One operates in two production facilities in Sweden and one in Poland and has a total of approximately 620 employees, of which approximately 65 are engineers. The company has a strong position in the Nordic market for contract manufacturing of electronics and electromechanics with a stable

Management changes in Qlife Holding AB

Qlife Holding AB is pleased to announce the appointment of Peter Thorsen as the new Chief Financial Officer (CFO) of the company, effective January 1st, 2024. Mr. Thorsen will succeed Kasper Boel Rousøe, bringing with him a wealth of financial expertise and leadership experience.Peter Thorsen is a Certified Public Accountant (CPA) with an impressive background in finance, having previously served in key roles at prominent organizations such as EY, DSV A/S, Domea, Widex A/S, and TeliaSonera. His extensive experience in finance leadership positions, combined with his strategic vision and

Synergi launches spot-price optimization for heat pumps to serve Europe’s 20 million heating and cooling devices

The new “smart climate” feature is one of the first in Europe and could help households save 20% percent off their heat pump electricity costs.Helsinki (December 1st, 2023)–Synergi , a Finnish technology company accelerating the transition toward sustainable energy sources with smart software solutions for consumers and businesses, announces the launch of a new app feature, “Smart Climate,” to help households use heat pumps optimally and save on their electricity bills.  This year, Synergi launched a roster of smart electricity features within its consumer

2023 Season of the FIA Smart Driving Challenge: Winner crowned after final in Dubai, UAE

The FIA Smart Driving Challenge 2023 Season’s final was held in Dubai, UAE, with the support of FIA Member Club the Emirates Motorsports Organization (EMSO). Alexandre Stricher claimed the victory, after a safe and eco-friendly drive through the center of the city.  The live one-to-one final, between Alexandre Stricher and James Haigh, marked the end of the 2023 Season, which invited everyday drivers all around the world to drive in a safer and more eco-friendly way during their regular trips using the FIA SDC app.   The FIA Smart Driving Challenge annual season was launched in 2019

SUO 2023 Meeting: New Real World Evidence shows Significant Decrease in Risk of Bladder Cancer Recurrence with Blue Light Cystoscopy

Press release – Oslo, Norway, December 1, 2023: Photocure ASA (OSE: PHO), The Bladder Cancer Company, announces that new evidence from routine clinical practice in the Veterans Affairs (VA) healthcare system was presented at the 24[th] Annual Society of Urologic Oncology (SUO) meeting demonstrating a significantly reduced risk of tumor recurrence (33%) in non-muscle invasive bladder cancer (NMIBC) patients who received Blue Light Cystoscopy (BLC[®]) compared to patients who only underwent standard White Light Cystoscopy (WLC).The abstract and Poster entitled “Comparing white light versus

Aiforia’s transition to IFRS reporting

Aiforia Technologies Plc, Company release, December 1, 2023 08:30 a.m. EET. Aiforia Group (Aiforia Technologies Plc, together with its subsidiary Aiforia Inc.) will transition from the Finnish Accounting Standards (FAS) to International Financial Reporting Standards (IFRS).Aiforia estimates that the transition to IFRS reporting will improve the comparability of financial figures and increase the interest of international investors in the company. The IFRS transition date was 1 January 2022.   Aiforia will publish its first IFRS financial statements for the financial period ending 31.

Skanska signs additional contract for science building in Raleigh, USA, for USD 106M, about SEK 1.1 billion

Skanska has signed an additional contract with North Carolina State University to build its new integrative sciences building with STEM teaching (Science, Technology, Engineering, and Math) and research space in Raleigh, North Carolina, USA. The contract is worth USD 106M, about SEK 1.1 billion, which will be included in the US order bookings for the fourth quarter of 2023.The 15,300 square-meter (165,000-SF) project includes classrooms, teaching labs, research core facilities, collaboration/study space, café, and office space. The building design will promote creativity and collaboration

Wihlborgs to build a new 11,600 m² school outside Copenhagen

Wihlborgs will build a new school for the privately owned Nordsjællands Grundskole & Gymnasium (NGG) in Hørsholm, north of Copenhagen, with room for 1,500 students and employees.The detailed development plan has been adopted by Hørsholm Municipal Council, which means that the project can commence. The new school will include a primary and secondary school, international school and a preschool. The school will be three storeys totaling 11,600 m² in a module-like structure with roof terraces. This way, the building can be split up or expanded in the future as necessary. The building will

Brunswick säljer sin andel i Hemmaplan till Bonnier Fastigheter

2023-12-01 Brunswick Real Estate (”Brunswick”) säljer sin ägarandel i Fastighets AB Hemmaplan (”Hemmaplan”) till Bonnier Fastigheter Invest AB. Hemmaplan äger, förvaltar och utvecklar centrumfastigheter i områden präglade av socioekonomiska utmaningar, för att därigenom driva hållbar, positiv och lönsam samhällsutveckling.Hemmaplan har sedan starten 2021 förvärvat 50 % av Rosengård Centrum samt 100 % av Gottsunda Centrum, där tydliga mätbara hållbarhetsmål, och arbetet för att nå dessa, utgör kärnan i bolagets affärsplan. Brunswick kommer tills vidare att fortsätta bistå Hemmaplan med

There are no items matching the current filter
There are no more items matching the current filter
Back to top